| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/20/2013 | CN102985110A Novel modulators |
| 03/20/2013 | CN102985103A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex |
| 03/20/2013 | CN102985075A Canagliflozin containing tablets |
| 03/20/2013 | CN102984957A Array of age-tailored nutritional formula with optimum fat content |
| 03/20/2013 | CN102978185A Oligosaccharides comprising an aminooxy group and conjugates thereof |
| 03/20/2013 | CN102977218A Method for extracting polysaccharide from buckwheat brans |
| 03/20/2013 | CN102977212A Compositions comprising anti-IGF-1r antibodies and methods for their production |
| 03/20/2013 | CN102977091A Application of aromatic alkanoyl tetrahydro-beta-carboline and derivative thereof in treatment of metabolic disease |
| 03/20/2013 | CN102977085A 2-aryl-benzo[d]oxazole and 2-aryl-benzo[d]thiazole derivatives, and preparation methods and application thereof |
| 03/20/2013 | CN102976997A Polymorphic substance of atorvastatin semi-strontium salt as well as preparation method and application of polymorphic substance as HMG-CoA (Hydroxy Methylglutaryl Coenzyme A) enzyme inhibitor |
| 03/20/2013 | CN102976996A Polymorphic substance of atorvastatin semi-strontium salt as well as preparation method and application of polymorphic substance as HMG-CoA (Hydroxy Methylglutaryl Coenzyme A) enzyme inhibitor |
| 03/20/2013 | CN102976973A Selective androgen receptor modulator and method for using thereof |
| 03/20/2013 | CN102976962A L-ornithine-aspirin double salt and its preparation method and use |
| 03/20/2013 | CN102976943A Alpha-crystal form substance of danshinolic acid A, preparation method, pharmaceutical composition and application |
| 03/20/2013 | CN102974032A Deserted type body surface pulse electrostimulation paste |
| 03/20/2013 | CN102973942A Controlled release complex composition comprising angiotensin-II-receptor blockers and HMG-CoA reductase inhibitors |
| 03/20/2013 | CN102973915A Pill for treating hyperlipidemia |
| 03/20/2013 | CN102973901A Traditional Chinese medicine composition for reducing blood fat |
| 03/20/2013 | CN102973869A Chinese medicinal preparation for improving immunity, diminishing inflammation, removing stasis and eliminating toxicity |
| 03/20/2013 | CN102973831A Preparation method of Huaqi preparation |
| 03/20/2013 | CN102973825A Chinese traditional medicine composite for curing diabetes |
| 03/20/2013 | CN102973821A Composition having vascular headache improvement effect |
| 03/20/2013 | CN102973814A Formula of traditional Chinese medicine capable of purifying blood, protecting heart and brain, and enhancing immunity, and preparation method thereof |
| 03/20/2013 | CN102973812A Pill for diabetes treatment and care |
| 03/20/2013 | CN102973810A Potentilla disclor bunge-dendrobe tea |
| 03/20/2013 | CN102973795A Traditional Chinese medicine used for treating diabetes |
| 03/20/2013 | CN102973787A Traditional Chinese medicine used for treating diabetic cardiac autonomic neuropathy |
| 03/20/2013 | CN102973785A Traditional Chinese medicine for treatment of diabetic cardiomyopathy |
| 03/20/2013 | CN102973720A Compound traditional Chinese medicine preparation for treating hyperlipidemia, and preparation method thereof |
| 03/20/2013 | CN102973693A Pharmaceutical composition used for relaxing bowels to lose weight, and preparation method and application thereof |
| 03/20/2013 | CN102973654A Calcium and zinc gluconate capsule |
| 03/20/2013 | CN102973616A High-bioactivity ganoderma spore oil and supercritical preparation method thereof |
| 03/20/2013 | CN102973602A Cattle fast-dissolving tablet with calcium hydroxymethionine as major ingredient and preparation process of tablet |
| 03/20/2013 | CN102973592A Application of dextran sulfate in preparing medicament for treating diabetes mellitus |
| 03/20/2013 | CN102973589A Application of alginic acid in preparing medicament for treating diabetes mellitus |
| 03/20/2013 | CN102973588A Application of carrageenan in preparing medicament for treating diabetes mellitus |
| 03/20/2013 | CN102973566A DPAs and high-molecular polymer used for hyperlipemia and for reducing fat animal food absorbing amount and fat tissue weight |
| 03/20/2013 | CN102973557A Compound amino acid injection (18AA-III) composition |
| 03/20/2013 | CN102973556A Compound amino acid injection (18AA-IV) composition |
| 03/20/2013 | CN102973543A Weight-loss effervescent tablets |
| 03/20/2013 | CN102973537A Probucol spansule for treatment of hypercholesteremia and production method thereof |
| 03/20/2013 | CN102973535A Probucol controlled-release tablet for treatment of hypercholesteremia and production method thereof |
| 03/20/2013 | CN102973517A Probucol controlled-release particle for treatment of hypercholesteremia and production method thereof |
| 03/20/2013 | CN102972756A Tea polyphenol blood-fat reducing capsules |
| 03/20/2013 | CN102972672A Drug composite effervescent granule for supplementing nutrition and preparation method thereof |
| 03/20/2013 | CN102972594A Antihypertensive tea capable of effectively preventing atherosclerosis, and preparation method thereof |
| 03/20/2013 | CN102512442B Zinc chelate-containing compound vitamin oral nano-emulsion and preparation method for same |
| 03/20/2013 | CN102512437B Medicinal composition of liposoluble vitamin injection (I) and water-soluble vitamin for injection and preparation method thereof |
| 03/20/2013 | CN102499939B Pharmaceutical compositions of fat-soluble vitamins for injection and water-soluble vitamins for injection and preparation method thereof |
| 03/20/2013 | CN102441064B Traditional Chinese medicine composition for treating diabetes and preparation thereof |
| 03/20/2013 | CN102429902B Pharmaceutical composition of alanyl glutamine and compound amino acid |
| 03/20/2013 | CN102319402B Chinese medicinal natural weight-reducing medicament for conditioning whole bodies |
| 03/20/2013 | CN102319327B Traditional Chinese medicine for internally and externally treating diabetic foot |
| 03/20/2013 | CN102302644B Traditional Chinese medicine for treating diabetic peripheral neuropathy and preparation method thereof |
| 03/20/2013 | CN102293762B Application of curcumin derivative in preparation of medicines for resisting diabetes and complication thereof |
| 03/20/2013 | CN102227223B Mineral absorption improver, and method for improving absorption of minerals |
| 03/20/2013 | CN102199206B Insulin analogue having quick response and stability under acidic condition and preparation thereof |
| 03/20/2013 | CN102178847B Vacuum freeze-drying processing method of dendrobium officinale |
| 03/20/2013 | CN102145062B Active extracts of rosa roxburghii tratt fruit, and preparation method, detection method and application thereof |
| 03/20/2013 | CN102079765B 9-O-glucoside-berberine salt, and preparation method and application thereof |
| 03/20/2013 | CN101991590B Stilbene glucoside medical composition and preparation method thereof |
| 03/20/2013 | CN101991580B Application of lanostane and poria cocos extracts in diabetes treatment |
| 03/20/2013 | CN101912408B Application of alginate sulfuric ester in preparing drugs for preventing and treating diabetes and vascular diseases |
| 03/20/2013 | CN101785789B Method for preparing animal gall powder |
| 03/20/2013 | CN101781287B Irbesartan hydrobromide and preparation method thereof |
| 03/20/2013 | CN101772499B Tricyclic N-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
| 03/20/2013 | CN101543546B Antioxidative substance and composition and use thereof |
| 03/20/2013 | CN101502620B Pure natural concentrated health-care capsule for protecting liver, expelling toxin and lowering lipid |
| 03/19/2013 | US8399520 Selective estrogen receptor modulator |
| 03/19/2013 | US8399479 Modulators of cystic fibrosis transmembrane conductance regulator |
| 03/19/2013 | US8399469 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 03/19/2013 | US8399418 Monosebacate of pyrazole derivative |
| 03/19/2013 | US8399408 Method for treating diabetes using neurturin |
| 03/19/2013 | US8399407 Non-standard insulin analogues |
| 03/19/2013 | US8398967 Particle formulations for use in pharmaceutical compositions |
| 03/19/2013 | CA2706872C Intermediates for the preparation of lipoxin a4 analogs |
| 03/19/2013 | CA2488499C Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives ("statins"),combinations thereof as well as manufacturing of these pharmaceutical compositions |
| 03/19/2013 | CA2354638C Expression of secreted human alpha-fetoprotein in transgenic animals |
| 03/14/2013 | WO2013036914A1 Materials and methods for modulating immune responses |
| 03/14/2013 | WO2013036875A1 Ceramidase and cell differentiation |
| 03/14/2013 | WO2013036303A2 Induced tolerogenic dendritic cells to reduce systemic inflammatory cytokines |
| 03/14/2013 | WO2013035827A1 Novel olefin derivative |
| 03/14/2013 | WO2013035797A1 Method for cultivating seaweed and method for producing alginic acid-containing composition |
| 03/14/2013 | WO2013035757A1 Preparation comprising hexose-6-phosphate-modified cholesterol derivative |
| 03/14/2013 | WO2013035423A1 Pharmaceutical composition containing candesartan cilexetil |
| 03/14/2013 | WO2013034546A1 Fish-protein hydrolysates used in preventing and/or treating metabolic disorders such as metabolic syndrome particularly associated with obesity |
| 03/14/2013 | WO2013034119A1 4-methylcatechol derivatives und use thereof |
| 03/14/2013 | WO2013003731A3 Methods of treating recurrent meibomian glands disorder and thereby decreasing the frequency of recurrence |
| 03/14/2013 | WO2012173422A9 A conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof |
| 03/14/2013 | WO2012169863A3 5-carbamoyl-adamantan-2-yl amide derivatives, pharmaceutically acceptable salts thereof and preparation process thereof |
| 03/14/2013 | US20130066069 Processes for preparing substituted pyrimidines |
| 03/14/2013 | US20130066052 Ucp4 |
| 03/14/2013 | US20130065956 Composition and/or method for preventing onset and/or recurrence of cardiovascular events |
| 03/14/2013 | US20130065914 Halogen or cyano substituted thieno [2,3-d]pyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions |
| 03/14/2013 | US20130065911 N-(5-cycloalkyl- or 5-heterocyclyl-)-pyridin-3-yl carboxamides |
| 03/14/2013 | US20130065909 Fatty acid fumarate derivatives and their uses |
| 03/14/2013 | US20130065906 New compounds, pharmaceutical compositions and uses thereof |
| 03/14/2013 | US20130065901 2-aminopyridine analogs as glucokinase activators |
| 03/14/2013 | US20130065899 Heteroaryl compounds and uses thereof |
| 03/14/2013 | US20130065897 Compounds, preparation and uses thereof |